Fatal or life-threatening unexpected ADRs must be reported to regulatory authorities within what timeframe after first knowledge?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

Fatal or life-threatening unexpected ADRs must be reported to regulatory authorities within what timeframe after first knowledge?

Explanation:
Fatal or life-threatening unexpected adverse drug reactions are reported as SUSARs and must be reported to regulatory authorities within seven calendar days of the investigator first becoming aware of the event. This tight timeline ensures regulators receive urgent safety information quickly to protect participants and assess whether trial actions are needed. The other timeframes would delay communication and are not appropriate for such critical safety signals.

Fatal or life-threatening unexpected adverse drug reactions are reported as SUSARs and must be reported to regulatory authorities within seven calendar days of the investigator first becoming aware of the event. This tight timeline ensures regulators receive urgent safety information quickly to protect participants and assess whether trial actions are needed. The other timeframes would delay communication and are not appropriate for such critical safety signals.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy